Clinical & Experimental Allergy · 2018 · 86 citations · 25 references
Life SciencesImmunologyPharmacotherapyAllergyClinical ImmunologyImmunotherapyAllergen ImmunotherapyAllergic DiseaseEffector T Cell FunctionFood AllergensFood AllergyPeanut AllergyCytokine Expression RegulationFood Allergen ImmunotherapyFood Oral ImmunotherapyImmune Cell Activation MarkersImmune Suppression MechanismsImmunotherapy For Allergic DiseaseOmalizumab TherapyPeripheral Regulatory T Cells
BACKGROUND: Oral immunotherapy (OIT) successfully desensitizes patients with food allergies, but the immune mechanisms mediating its efficacy remain obscure. OBJECTIVES: We tested the hypothesis that allergen-specific regulatory T (Treg) cell function is impaired in food allergy and is restored by anti-IgE antibody (omalizumab)-supplemented OIT. METHODS: Peanut-specific T effector (Teff) and Treg cell proliferative responses, activation markers and cytokine expression were analysed by flow cytometry in 13 peanut-allergic subjects before the start of omalizumab-supplemented OIT and periodically in some subjects thereafter for up to 2 years. Peripheral blood regulatory T cells (Treg cells) were analysed for their peanut-specific suppressor function before and at 1 year following OIT. This study was registered on ClinicalTrials.gov (NCT01290913). RESULTS: Proliferation of allergen-specific Teff and Treg cells precipitously declined following the initiation of omalizumab therapy prior to OIT, followed by partial recovery after the initiation of OIT. At baseline, peanut-specific Treg cells exhibited a Th2 cell-like phenotype, characterized by increased IL-4 expression, which progressively reversed upon OIT. Peanut-specific Treg cell suppressor activity was absent at the start of omalizumab/OIT therapy but became robust following OIT. Absent peanut-specific Treg cell function could also be recovered by the acute blockade of IL-4/IL-4R receptor signalling in Treg cells, which inhibited their IL-4 production. CONCLUSIONS AND CLINICAL RELEVANCE: OIT supplemented by omalizumab promotes allergen desensitization through an initial omalizumab-dependent step that acutely depletes allergen-reactive T cells, followed by an increase in allergen-specific Treg cell activity due to the reversal of their Th2 cell-like programme. Improved Treg cell function may be a key mechanism by which OIT ameliorates food allergy.
25
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Federica Sallusto, Danielle Lenig, Reinhold Förster et al. · Nature · 1999 · 5.8K citations
Epigenetic Control of the foxp3 Locus in Regulatory T Cells
Stefan Floess, Jennifer Freyer, Christiane Siewert et al. · PLoS Biology · 2007 · 1.2K citations · Full text
Spatial Map of Human T Cell Compartmentalization and Maintenance over Decades of Life
Joseph J.C. Thome, Naomi Yudanin, Yoshiaki Ohmura et al. · Cell · 2014 · 581 citations · Full text